Peptide questions · Setmelanotide
How long does setmelanotide take to work?
Reviewed Evidence: EstablishedPublished by PepVault
Setmelanotide’s onset is 1–2 weeks (hunger), its peak effect comes at 52 weeks (BMI), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
The timeline’s basis: FDA Imcivree label (DailyMed, effective April 2026); Drugs@FDA approval history; TRANSCEND (Miller 2026); Roth 2024; Clément 2020; Haqq 2022. Approved only for obesity from acquired hypothalamic injury, BBS and POMC, PCSK1 or LEPR deficiency.
Setmelanotide week by week
The library places four of its research notes on setmelanotide on the days they cover, from day 1 to day 365: 3 on randomized trials and 1 on clinical data.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–14 (weeks 1–2) | The 0.5 mg start | Randomized trial |
| Days 1–14 (weeks 1–2) | The 2 mg start | Clinical data |
| Days 14–90 (weeks 2–13) | Why the skin darkens | Randomized trial |
| Days 15–365 (weeks 3–53) | 3 mg, the maintenance dose | Randomized trial |

Model. Individual results vary.
The setmelanotide timeline’s milestones
The library’s timeline for setmelanotide marks 5 points from week 1 to week 52, backed by clinical trial data overall.
- Week 1: Commonly reported: nausea and less hunger in the first days, with redness where the shot goes in
- Week 2: The label's starting dose runs 2 weeks before the first step up
- Week 4: Commonly reported: the skin, freckles and moles start to darken, an MC1 receptor effect that fades after stopping
- Week 16: In its hypothalamic-obesity phase 2, BMI was down 15% on average at 16 weeks
- Week 52: In the 2026 phase 3, BMI fell 16.5% against a 3.3% rise on placebo, and hunger scores fell further than on placebo
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why setmelanotide takes that long
Setmelanotide’s half-life is about 11 hours, so one dose is about 96.9% cleared after 2.3 days.
On its schedule (Daily SubQ) the doses overlap, and the level of setmelanotide keeps climbing for about 1.8–2.3 days before it levels off, so the first 1.8–2.3 days run below the level the later weeks hold.
The notes on setmelanotide follow the trials’ dose steps, 0.5mg, 2mg and 3mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.
Setmelanotide against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, setmelanotide among them; none of the others shares its onset of 1–2 weeks (hunger).
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does setmelanotide take to work?
Setmelanotide’s onset is 1–2 weeks (hunger), its peak effect comes at 52 weeks (BMI), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).
When does setmelanotide reach its peak effect?
By the library’s timeline, setmelanotide’s peak effect comes at 52 weeks (BMI), backed by clinical trial data.
How long is setmelanotide usually run?
The library’s timeline gives setmelanotide’s typical duration as ongoing; its cycle note says: FDA-approved for long-term use ("reduce excess body weight and maintain weight reduction long term"); its trials ran 52 to 66 weeks.
What does the library say about the first days on setmelanotide?
Its first note on setmelanotide, for days 1–14 (weeks 1–2), is “The 0.5 mg start”, resting on randomized trials.